Full history for every metric is available with a Kvantra account
Accolade, Inc. (ACCD)
Key financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 95 | 133 | 170 | 310 | 363 | 414 | 447 |
| Operating profit | $m | -114 | -184 | |||||
| Net profit | $m | -56 | -51 | -51 | -123 | -460 | -100 | -180 |
| EPS reported | $ | -1.33 | -2.25 | |||||
| Operating cashflow per share | $ | -0.22 | -0.22 | |||||
| Capex per share | $ | 0.17 | 0.17 | |||||
| FCF per share | $ | -0.38 | -0.38 | |||||
| Free cash flow | $m | -29 | -13 | |||||
| Net debt | $m | -28 | -225 | |||||
| Book value equity | $m | 445 | 313 | |||||
| Book value per share | $ | 5.95 | 3.88 | |||||
| Number of shares | m | 74.91 | 80.65 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.72 | 1.84 | |||||
| P/S LTM | x | 1.85 | 1.29 | |||||
| P/FCF LTM | x | -26.80 | -45.17 | |||||
| EV/EBITDA LTM | x | -11.89 | -7.93 | |||||
| EV/Sales LTM | x | 1.99 | 0.78 | |||||
| Earnings Yield LTM | % | -13.00% | -18.98% | |||||
| FCF Yield | % | -3.73% | -2.21% | |||||
| Quality | ||||||||
| ROE | % | -22.40% | -21.71% | |||||
| ROIC | % | -16.65% | -16.65% | |||||
| Operating margin | % | -27.63% | -27.63% | |||||
| Gross margin | % | 46.36% | 46.36% | |||||
| FCF/Sales | % | -6.92% | -6.92% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +14.09% | +14.99% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.12 | -0.45 | |||||
| Net Debt/EBITDA | x | -0.81 | -0.81 | |||||
| EBIT/Net interest | x | -39.89 | -39.89 | |||||
| Net debt/market cap | % | -3.66% | -39.17% | |||||
| Net debt/Equity | x | -0.06 | -0.72 | |||||
| Gross debt/equity | x | 0.54 | 0.09 | |||||
Company overview
Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Accolade, Inc. (ACCD)
Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free